Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis

Globally, Triple-negative breast cancer (TNBC) is an unsurpassed variant of breast cancer (BC) with a very high fatality rate, and disease burden. Nevertheless, the deficit of diagnostic markers and focused treatment are major hurdles for potent therapeutics. They are also the reason for bad outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandagopal, Srividhya, Misra, Sanjeev, Sankanagoudar, Shrimanjunath, Banerjee, Mithu, Sharma, Praveen, Ellen Pane, Stacey, Guerriero, Giulia, Shukla, Kamla Kant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152875/
https://www.ncbi.nlm.nih.gov/pubmed/36708551
http://dx.doi.org/10.31557/APJCP.2023.24.1.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152875/
https://www.ncbi.nlm.nih.gov/pubmed/36708551
http://dx.doi.org/10.31557/APJCP.2023.24.1.49

Ejemplares similares